Frequency of Xerostomia and Their Management in Upper Aerodigestive Tract Cancer Patients After the End of Radiotherapy (XEROSTOMIA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02857413|
Recruitment Status : Completed
First Posted : August 5, 2016
Last Update Posted : August 8, 2016
The aim of this study is the evaluation of the frequency of xerostomia and their management after radiotherapy in head and neck cancer.
The quality of life of these patients is also analysed with European Organization for Research and Treatment of Cancer Quality of life Questionnaire H&N35 (EORTC QLQ H&N35).
|Condition or disease|
|Head and Neck Neoplasms|
|Study Type :||Observational|
|Actual Enrollment :||42 participants|
|Official Title:||Assessment of Frequency of Xerostomia and Their Care Management in Upper Aerodigestive Tract Cancer Patients After the End of Radiotherapy|
|Study Start Date :||January 2016|
|Actual Primary Completion Date :||May 2016|
|Actual Study Completion Date :||July 2016|
- Frequency of xerostomia and their management after radiotherapy in head and neck cancer [ Time Frame: at enrollment ]patients describe the severity of their xerostomia and their management in a standardized questionnaire
- quality of life af patients after radiotherapy in head and neck cancer [ Time Frame: at enrollment ]patients describe their quality of life in a standardized questionnaire
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02857413
|Besançon, France, 25000|
|Principal Investigator:||Edouard Euvrard, MD||CHU Besançon|